IGF-1-BP3

IGF-1-BP3, also known as Insulin-like Growth Factor Binding Protein 3, is a protein that serves as the main carrier for Insulin-like Growth Factor 1 (IGF-1) in the bloodstream. It's a key component of the IGF-1 axis, which is primarily regulated by growth hormone (GH). IGF-1-BP3 forms a complex with IGF-1 and another protein, the acid-labile subunit (ALS), to transport IGF-1, increasing its stability and half-life in the circulation. This complex ensures that IGF-1, which has a very short half-life on its own, is available to tissues throughout the body for longer periods to mediate its growth-promoting effects.

Benefits & Side Effects

The benefits and side effects of IGF-1-BP3 are often discussed in the context of the entire IGF-1 axis, particularly with growth hormone (GH) and IGF-1 therapies.

• Benefits: IGF-1-BP3 is essential for the proper function of IGF-1, which is a major mediator of the anabolic and growth-promoting effects of GH. Its primary benefit is to stabilize IGF-1 and regulate its bioavailability, ensuring sustained signaling for processes like bone and tissue growth, and muscle repair.

• Side Effects: While IGF-1-BP3 itself is not typically administered as a drug, imbalances in its levels, particularly when related to GH or IGF-1 therapies, can lead to side effects. For example, high levels of IGF-1 and IGF-1-BP3 due to excessive GH can lead to conditions like acromegaly or gigantism (in children) which can cause abnormal growth, joint issues, and other health problems. Conversely, very low levels are associated with growth hormone deficiency.

---

Pros & Cons

The pros and cons of IGF-1-BP3 are intrinsic to its biological role rather than its use as a supplement.

• Pros: It is a crucial regulator of the body's growth and metabolic processes. By binding to IGF-1, it acts as a "buffer" that prevents rapid fluctuations in IGF-1 levels, providing a more stable and reliable signal for growth. This is why doctors often measure both IGF-1 and IGF-1-BP3 levels to get a stable, long-term picture of a patient's GH status, unlike the pulsatile nature of GH itself.

• Cons: The main "con" is that an imbalance in IGF-1-BP3 levels, whether too high or too low, is an indicator of an underlying health issue. For instance, low IGF-1-BP3 can be a sign of GH deficiency or severe malnutrition, while high levels might indicate an overproduction of GH from a pituitary tumor. It does not have an anabolic or androgenic ratio since it is a binding protein and not a steroid hormone.

---

Dosage, Half-Life & Detection Time

There is no dosage for IGF-1-BP3, as it is a naturally occurring protein and not a substance administered on its own. It is typically a component of the body's natural regulatory system for IGF-1.

• Half-Life: When bound in the ternary complex with IGF-1 and ALS, the half-life of IGF-1-BP3 is approximately 12 hours. On its own, the half-life of unbound IGFBP-3 is much shorter (30 to 90 minutes). The half-life of IGF-1 by itself is only about 10 minutes, which highlights the importance of IGF-1-BP3 in extending its presence in the body.

• Detection Time: Since IGF-1-BP3 is an endogenous protein, it's always present in the body. Its levels are typically measured in blood tests to diagnose conditions related to growth hormone deficiency or excess. Therefore, "detection time" is not applicable in the way it is for performance-enhancing drugs.

---

Sterogenic, Progestogenic & Prolactin Effects

IGF-1-BP3 does not have sterogenic, progestogenic, or prolactinic effects.

• Sterogenic/Progestogenic: IGF-1-BP3 is a binding protein, not a steroid hormone, and does not interact with steroid receptors to produce androgenic or progestogenic effects.

• Prolactin: While studies have shown that prolactin can influence the expression of the IGF-1-BP3 gene, IGF-1-BP3 itself does not have a direct prolactin-like effect on the body.

Anabolic Androgenic Ratio

The concept of an anabolic androgenic ratio does not apply to IGF-1-BP3. This ratio is used to compare the muscle-building (anabolic) effects of an androgenic steroid to its masculinizing (androgenic) effects. Since IGF-1-BP3 is not a steroid and has no androgenic properties, it cannot be assigned such a ratio.